| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2965451 | Journal of Cardiovascular Disease Research | 2013 | 6 Pages |
Abstract
Pollypill decreases various surrogate endpoints related to cardiovascular outcome, but with the increased chance of side effects as compared to control.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jaykaran Charan, Jagdish Prasad Goyal, Deepak Saxena,